Literature DB >> 2956430

Painful palmar and plantar erythema associated with hepatic artery infusion of 5-fluoro-2'deoxyuridine.

M N Neuss, O E Akwari, D F Stevenson, B J Goodwin.   

Abstract

Painful palmar and plantar erythema is an uncommon systemic complication of chemotherapy and has been reported in association with methotrexate, cystosine arabinoside, doxorubicin, and 5-fluorouracil. The authors report a case in which the syndrome was precipitated by hepatic artery infusion of 5-FUdR. The previous recommendation that treatment of patients developing painful palmar-plantar erythema from other drugs may be successfully resumed using intrahepatic arterial infusion of FUdR must be reconsidered in light of the present report.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956430      PMCID: PMC2625536     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

Authors:  J J Lokich; C Moore
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

2.  Erythema and desquamation after high-dose methotrexate.

Authors:  L A Doyle; C Berg; G Bottino; B Chabner
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

3.  Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.

Authors:  N Kemeny; J Daly; P Oderman; M Shike; H Chun; G Petroni; N Geller
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

4.  Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.

Authors:  G R Weiss; M B Garnick; R T Osteen; G D Steele; R E Wilson; D Schade; W D Kaplan; L M Boxt; K Kandarpa; R J Mayer
Journal:  J Clin Oncol       Date:  1983-05       Impact factor: 44.544

5.  A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine.

Authors:  W L Gluck; O E Akwari; F M Kelvin; B J Goodwin
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

6.  High-dose cytosine arabinoside therapy for refractory leukemia.

Authors:  R H Herzig; S N Wolff; H M Lazarus; G L Phillips; C Karanes; G P Herzig
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.